← Open Payments lookup

MILLICENT STETTLER: Open Payments

NPI 1609452986 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,318 in 68 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $702 · 2025 $1,318

Food & beverage: $1,318
CompanyPaymentsAmount
PFIZER INC.18$230
Dexcom, Inc.3$158
E.R. Squibb & Sons, L.L.C.9$148
Novo Nordisk Inc10$146
Lilly USA, LLC6$130
GlaxoSmithKline, LLC.5$103
Bayer Healthcare Pharmaceuticals Inc.2$89
AstraZeneca Pharmaceuticals LP4$82
Exact Sciences Corporation2$44
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36

Products named: ELIQUIS, DEXCOM G7 GSS (161), CAMZYOS, MOUNJARO, Kerendia, TRELEGY ELLIPTA, Rybelsus, Ozempic.

Industry payments across VA — which companies pay providers there.